The acquisitions are part of Steris’s efforts to its healthcare segment and provide niche services to customers, according to a company statement.
Healthcare giant Steris (NYSE:STE) is looking to "significantly expand" its presence in the gastrointestinal devices market with the $270 million acquisition of U.S. Endoscopy Group, the company announced this week.
U.S. Endoscopy, which employs about 400 and generated about $70 million in revenue in 2011, designs, manufactures and sells devices and support accessories used in gastrointestinal and urology procedures.
Join STERIS Isomedix Services for a TechTeam seminar on topics critical to success in medical device sterilization. The event, being held September 11-12 in Mahwah, New Jersey, will provide attendees the opportunity to gain an in-depth understanding of the relationship between sterilization and medical device design, validation, manufacturing and packaging.
The medical device industry’s efforts to repeal an impending 2.3% tax on sales continue to run in high gear as Ohio’s med-tech industry discusses impacts with local legislators and a Congressional GOP group takes the rhetoric and runs with it.
The Sunnyvale, Calif.-based radiosurgery device maker reported losses of $14.9 million, or 21¢ per share, on sales of $101.8 million during the 3 months ended March 31.
Cooper Cos. (NYSE:COO) today announced that the U.S. Food and Drug Administration has granted a Special 510(k) clearance for CooperVision’s Avaira Toric two-week silicone hydrogel contact lenses for astigmatism.
CooperVision will re-launch Avaira Toric with shipments available for select distribution beginning in early May 2012.
Steris Corp. (NYSE:STE) landed special 510(k) clearance to modify its System 1E sterilizers, the replacement systems for the troubled System 1 devices that were the center of a 2-year row with the FDA.
The Mentor, Ohio-based device maker won the FDA’s approval to update existing SS1E devices in the field with modified software, which will also be applied to all new shipments, effective immediately.
MASSDEVICE ON CALL — A growing number of students claim to know a peer who is using prostitution to pay for med school, according to a new study published in the British Medical Journal.
1 in 10 students surveyed claimed to know someone in the sex trade as a last resort for paying tuition, up from 6% of those surveyed in 2006 and 4% in 2002.
Thoratec (NSDQ:THOR) shares are up more than 11% today after the heart pump maker put mid-double-digit profit growth numbers on the board for the 4th quarter and full-year 2011.
The Pleasanton, Calif.-based cardiac assist device maker logged profits of $15.3 million, or 25 cents per diluted share, on sales of $109.4 million for the 3 months ended Dec. 31, 2011. That’s a 46.4% bottom-line gain and a top-line boost of 12.1%, compared with profits of $10.5 million, or 17 cents diluted EPS, on sales of $97.6 million during Q4 2010.
Financial projections from AngioDynamics (NSDQ:ANGO) about its $372 million deal to acquire Navilyst Medical show that it expects to reap some significant rewards from the merger over the short and long terms.